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Conclusions: Interpretation of uncertainty scenarios with TCP 
and NTCP models can identify endpoints at risk in the 
presence of uncertainties. TCP uncertainty is less in PTV 
plans compared to CTV plans. In contrast, for the risk of 
NTCP increase, CTV plans are more robust. The endpoints at 
risk can be used as an input to guide robust optimization, for 
instance target coverage or the max dose in the brainstem. 
For this cohort, robust optimization is not needed for random 
shift errors. Further refinement of endpoint specific 
thresholds and TCP/NTCP models is required to optimize this 
method. 
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Purpose/Objective: To create a process of standardization 
for planning and delivery of IMRT in multiple CTCs (Cancer 
Treatment Centers) in Poland and develop a Quality 
Assurance (QA) program and allow data mining at a central 
hub. 
Materials and Methods: The Euromedic Cancer Centers 
initiated a system to systematically approach the problem of 
standardization of IMRT in multiple centers in Poland. These 
centers were geographically located in Otwock, Koszalin, 
Poznan and Walbrzych. Phase I: The group required 
standardization in the following areas: 1) contouring, 2) 
dosimetric parameters for organs at risk and target, 3) the 
development of a protocol book that would define treatment 
and contouring of all TNM stages of all cancers, 4) a library of 
evidence-based medicine for treatment of all diseases, 5) the 
development of site specific experts within the Euromedic 
system who would provide review of contouring and 
treatment plans, 6) biyearly training courses in IMRT, 7) 
standardization of physics QA, immobilization and simulation 
techniques, 8) have a similar treatment planning, EMR, and 
record and verify system at all facilities, 9) peer review of 
IMRT cases, and 10) define KPIs (Key Performance 
Indicators)and CPIs (Clinical Performance Indicators) for the 
system. Phase II: 1) a centralized hub with a relational 
database that would store all data within the Euromedic 
system and direct contours and treatment plans to the 
defined site specific expert, 2) tools within the hub that 
could be utilized for contouring, fusion, and allow access to 
references, 3) KPI and CPI measured at the central hub, 4) 
establish the hub as a training center, and 5) evaluation 
metrics for physicists and physicians to be extracted from the 
hub. 
Results: In the three year time window since the start of this 
project phase I has been completed for Gynecological, 
Gastrointestinal, Head and Neck, Lung and Genitourinary 
malignancies. Peer review sessions by site specific experts 
are being performed, protocols are being utilized with 
evidence based medicine, immobilization, dosimetric 
constraints, physics and machine QA, KPI’s and CPI’s are part 
of each of the CTCs’. 
Phase II : The IT infrastructure of the hub has been put in 
place and the relational database is being constructed. 
Formal testing of the hub will begin first quarter 2015 with 
expected completion first quarter 2016. 
Conclusions: The Euromedic group was able to build the 
framework for standardization of IMRT. Phase I has been 
completed. The implementation of the hub and spoke model 
with the integration of Bioinformatics will begin first quarter 
2016.  
 
PO-0793 
Developing and implementing a radiotherapy research 
activity assessment tool  
S. Goldsworthy1, B. Roe1, S. McGrail1, J.M. Latour2, 
K. Morgan1 
1Musgrove Park Hospital, Radiotherapy The Beacon Centre, 
Taunton Somerset, United Kingdom 
2Musgrove Park Hospital, Clinical School, Taunton Somerset, 
United Kingdom 
 
Purpose/Objective: Cancer research in the National Health 
Service (NHS) has increased by 10.5% in three years since the 
formation of the National Cancer Research (NCRN) networks 
in 2000. Additionally there is a positive cultural change 
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driving research locally at NHS institutions. Clinical studies 
afflict changes to practice, impacting clinical service. The 
initial enthusiasm from clinical staffs to embark on a project 
has to be balanced against the implications of resources, 
costs and other developments. There is no standardised 
method to assess the impact of research projects on clinical 
practice. Therefore, the aim of this project was to develop 
and implement a Radiotherapy Research Activity Assessment 
Tool (RAAT) to assess the feasibility of newly proposed 
research projects within clinical settings. 
Materials and Methods: A multi-step development method 
was used. The steps involved the principals of Quality 
Function Deployment (QFD). The consecutive steps involved 
developing a user friendly and replicable tool and would fit 
on one A4 page. The process involved multi-professionals and 
patients throughout the design process. The tool was 
preliminary tested on usability among 8 stakeholders on a 10-
point scale (1=poor; 10=very good). Agreement was 
correlated to the initial probability scoring of the 8 
stakeholders. 
Results: The RAAT was developed in an e-form available in 
Microsoft Excel. The tool included details such as project 
title, date ranges and approval tab. It also needed to include 
meeting columns of where the project should be presented, 
along with details such as scope, and benefits to the clinical 
setting. A probability rating was included giving an indication 
of project success or failure. Finally a column to project the 
recruitment level of trials and comment boxes for additional 
information were added.  
The tool scored an average of 7/10 for usability and so 
alterations were made. Agreement between stakeholders 
resulted in a significant correlation of p=0.01 (Pearson = 
899).  
 
Conclusions: In conclusion the RAAT seems to be feasible in 
clinical practice, and provide a framework to guide the 
decision making process of accepting a research project. The 
tool calls for further testing of usability and long term 
implications on all stakeholders. 
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Purpose/Objective: Radiation therapists are an integral part 
of the radiation oncology team and their roles and 
responsibilities are expanding to advanced levels within 
clinical, educational and research settings in some countries. 
However, despite this expansion there is the perception that 
research with a specific focus on the radiation therapist 
continues to be underrepresented in the radiation oncology 
literature. We performed a novel review to identify recent 
ESTRO conference abstracts with a focus on the radiation 
therapist in order to quantify, describe and identify possible 
trends in this important area of study. 
Materials and Methods: With the aid of a medical librarian 
and the ESTRO events Co-ordinator we identified all 
published abstracts from the proceedings of the ESTRO 
